{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:59:19Z","timestamp":1790060359099,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.clinthera.2015.03.012","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T03:18:33Z","timestamp":1428635913000},"page":"1259-1269","source":"Crossref","is-referenced-by-count":23,"title":["Hypersensitivity Reactions to Oxaliplatin: Identifying the Risk Factors and Judging the Efficacy of a Desensitization Protocol"],"prefix":"10.1016","volume":"37","author":[{"given":"Tetsuya","family":"Okayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuko","family":"Sugatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohisa","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kokura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kuriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terukazu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Kamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Katada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eigo","family":"Otsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneharu","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2015.03.012_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0753-3322(89)90003-6","article-title":"Oxalato-platinum or 1-OHP, a third-generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum","volume":"43","author":"Math\u00e9","year":"1989","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clinthera.2015.03.012_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1533-0028(11)70509-6","article-title":"N9741: a phase III study comparing irinotecan to oxaliplatin-containing regimens in advanced colorectal cancer","volume":"2","author":"Goldberg","year":"2002","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clinthera.2015.03.012_bib3","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib4","first-page":"1671","article-title":"Hypersensitivity reactions to oxaliplatin: incidence and management","volume":"18","author":"Gowda","year":"2004","journal-title":"Oncology"},{"key":"10.1016\/j.clinthera.2015.03.012_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bjc.6601155","article-title":"Hypersensitivity reactions related to oxaliplatin (OHP)","volume":"89","author":"Brandi","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clinthera.2015.03.012_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1081-1206(10)60078-6","article-title":"Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents","volume":"102","author":"Lee","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib7","first-page":"1125","article-title":"Effect of preliminary medication on oxaliplatin hypersensitivity. [in Japanese]","volume":"36","author":"Sato","year":"2009","journal-title":"Gan To Kagaku Ryoho"},{"key":"10.1016\/j.clinthera.2015.03.012_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1200\/JCO.1999.17.4.1141","article-title":"Clinical features of hypersensitivity reactions to carboplatin","volume":"17","author":"Markman","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00000421-200212000-00020","article-title":"Hypersensitivity reaction to cisplatin during chemoradiation therapy for gynecologic malignancy","volume":"25","author":"Koren","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10147-009-0883-6","article-title":"Oxaliplatin-induced allergic reaction in patients with colorectal cancer in Japan","volume":"14","author":"Shibata","year":"2009","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0929-6646(10)60064-2","article-title":"Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions","volume":"109","author":"Shao","year":"2010","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.clinthera.2015.03.012_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000205263","article-title":"Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review","volume":"76","author":"Kim","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.clinthera.2015.03.012_bib13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.7314\/APJCP.2012.13.4.1209","article-title":"Hypersensitivity reactions to oxaliplatin: clinical features and risk factors in Koreans","volume":"13","author":"Kim","year":"2012","journal-title":"Asian Pacific journal of cancer prevention: APJCP"},{"key":"10.1016\/j.clinthera.2015.03.012_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000320613","article-title":"Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX","volume":"79","author":"Mori","year":"2010","journal-title":"Oncology"},{"key":"10.1016\/j.clinthera.2015.03.012_bib15","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1200\/JCO.2006.07.5630","article-title":"OPTIMOX1 in advanced colorectal cancer: lack of evidence for a stop-and-go strategy","volume":"24","author":"Rosa","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2005.03.0106","article-title":"OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer\u2013a GERCOR study","volume":"24","author":"Tournigand","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib17","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1200\/JCO.2006.10.4380","article-title":"Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer","volume":"25","author":"de Gramont","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib18","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.clon.2011.04.005","article-title":"Re-challenging patients with oxaliplatin allergy: the successful use of a standardised pre-medication protocol in a single institute","volume":"23","author":"Siu","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10147-010-0170-6","article-title":"High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin","volume":"16","author":"Kidera","year":"2011","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ygyno.2009.10.070","article-title":"The prophylactic conversion to an extended infusion schedule and use of premedication to prevent hypersensitivity reactions in ovarian cancer patients during carboplatin retreatment","volume":"116","author":"O\u05f3Cearbhaill","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12094-012-0909-9","article-title":"Effectiveness of oxaliplatin desensitization protocols","volume":"15","author":"Cortijo-Cascajares","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3816\/CCC.2009.n.017","article-title":"Hypersensitivity reactions to oxaliplatin: a retrospective study and the development of a desensitization protocol","volume":"8","author":"Syrigou","year":"2009","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.clinthera.2015.03.012_bib23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.5414\/CPP45606","article-title":"Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin","volume":"45","author":"Rosique-Robles","year":"2007","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2015.03.012_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.pap.0000249924.90645.5b","article-title":"Oxaliplatin hypersensitivity: case report and successful repeat desensitization","volume":"14","author":"Edmondson","year":"2007","journal-title":"Am J Ther"},{"key":"10.1016\/j.clinthera.2015.03.012_bib25","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.clinthera.2008.06.007","article-title":"Desensitization to oxaliplatin with two stages of premedication in a patient with metastatic rectal cancer","volume":"30","author":"Nozawa","year":"2008","journal-title":"Clin Ther"},{"issue":"suppl 1","key":"10.1016\/j.clinthera.2015.03.012_bib26","first-page":"S5","article-title":"Adjuvant treatment of colon cancer MOSAIC study\u2019s main results [in French]","volume":"93","author":"Andre","year":"2006","journal-title":"Bull Cancer"},{"key":"10.1016\/j.clinthera.2015.03.012_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0090-8258(03)00178-1","article-title":"Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity","volume":"89","author":"Rose","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib28","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdj042","article-title":"Hypersensitivity reactions to oxaliplatin: experience in a single institute","volume":"17","author":"Siu","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000178163","article-title":"Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience","volume":"76","author":"Polyzos","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.clinthera.2015.03.012_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/annonc\/mdg092","article-title":"Skin testing and hypersensitivity reactions to oxaliplatin","volume":"14","author":"Garufi","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib31","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1200\/JCO.2003.05.539","article-title":"Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity","volume":"21","author":"Markman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinthera.2015.03.012_bib32","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1345\/aph.1E532","article-title":"Successful desensitization to oxaliplatin","volume":"39","author":"Mis","year":"2005","journal-title":"Ann Pharmacother"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815001496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291815001496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T18:52:58Z","timestamp":1537728778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291815001496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0149291815001496"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2015.03.012","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}